Free. Unsubscribe any time.
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
SUPERNUS PHARMACEUTICALS, INC. filed 22 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 36 transactions and 609,194 shares. None carries the SEC's AFF10B5ONE flag; all 22 name a plan in a footnote. 14 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-03-18, came 2 days after the one before it (2026-03-16) and reports 22 transactions against 5 in the filing before it.
- The sales it reports total 107,250 shares, 72,250 more than the 35,000 in the filing before it.
- Its 22 plan statements rank 270th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 4 have more plan statements on file than it and 6 have fewer.
- Its 22 filings on file run from 2025-08-08 to 2026-03-18, and state 6 plan adoption dates, from 2022-09-15 to 2025-12-12.
Trades in SUPERNUS PHARMACEUTICALS, INC. 36
- Khattar Jack A. — 2025-08-06 · S · 38,500 shares
- Khattar Jack A. — 2025-08-06 · S · 38,000 shares
- Khattar Jack A. — 2025-08-06 · S · 63,500 shares
- Sensenig Bethany — 2025-08-14 · S · 5,369 shares
- Khattar Jack A. — 2025-08-22 · S · 1,500 shares
- NEWHALL CHARLES W III — 2025-08-22 · S · 1,412 shares
- Khattar Jack A. — 2025-08-25 · S · 1,000 shares
- NEWHALL CHARLES W III — 2025-08-25 · S · 1,000 shares
- Khattar Jack A. — 2025-08-27 · S · 10,650 shares
- NEWHALL CHARLES W III — 2025-08-27 · S · 3,588 shares
- Khattar Jack A. — 2025-08-28 · S · 24,150 shares
- Khattar Jack A. — 2025-09-05 · S · 55,578 shares
Adoption dates in SUPERNUS PHARMACEUTICALS, INC. 6
- 2022-09-15 — stated in 1 filing
- 2024-11-14 — stated in 12 filings
- 2025-03-03 — stated in 4 filings
- 2025-05-15 — stated in 2 filings
- 2025-09-15 — stated in 1 filing
- 2025-12-12 — stated in 2 filings
Results prints in SUPERNUS PHARMACEUTICALS, INC. 14
- 2025-04-23
- 2025-05-06
- 2025-07-22
- 2025-08-05
- 2025-10-21
- 2025-11-04
- 2026-02-12
- 2026-02-24
- 2026-04-22
- 2026-05-05
- 2026-07-22
- 2026-08-03
Trades before a print in SUPERNUS PHARMACEUTICALS, INC. 2
- 5 days before the 2026-02-24 print — 2026-02-19 · S · Sensenig Bethany · 1,217 shares
- 5 days before the 2026-02-24 print — 2026-02-19 · S · Sensenig Bethany · 3,258 shares
- 12 days before the 2025-10-21 print — 2025-10-09 · S · Khattar Jack A. · 58,371 shares
- 12 days before the 2025-10-21 print — 2025-10-09 · S · Khattar Jack A. · 1,529 shares
- 12 days before the 2025-10-21 print — 2025-10-09 · S · NEWHALL CHARLES W III · 23,800 shares
- 12 days before the 2025-10-21 print — 2025-10-09 · S · NEWHALL CHARLES W III · 1,200 shares
- 19 days before the 2025-10-21 print — 2025-10-02 · S · Khattar Jack A. · 1,904 shares
- 20 days before the 2025-10-21 print — 2025-10-01 · S · Khattar Jack A. · 40,173 shares
- 21 days before the 2025-10-21 print — 2025-09-30 · S · Khattar Jack A. · 8,588 shares
- 22 days before the 2025-10-21 print — 2025-09-29 · S · Khattar Jack A. · 10,235 shares
- 28 days before the 2025-10-21 print — 2025-09-23 · S · Khattar Jack A. · 29,513 shares
- 29 days before the 2025-10-21 print — 2025-09-22 · S · Khattar Jack A. · 16,587 shares
Interval to SUPERNUS PHARMACEUTICALS, INC.’s next reported results date
How the interval and sources are counted →
- 2within 5 days
- 2within 10 days
- 5shortest, days
- 0no later print
- Sensenig Bethany 2026-02-19 · S · 5 days before the 2026-02-24 print
- Sensenig Bethany 2026-02-19 · S · 5 days before the 2026-02-24 print
Adoption dates SUPERNUS PHARMACEUTICALS, INC. states
- 2022-09-15 in 1 filing
- 2024-11-14 in 12 filings
- 2025-03-03 in 4 filings
- 2025-05-15 in 2 filings
- 2025-09-15 in 1 filing
- 2025-12-12 in 2 filings
Filing text: “10b5-1 trading plan adopted March 3, 2025”
Reported results dates on file
- 2025-02-11
- 2025-02-25
- 2025-04-23
- 2025-05-06
- 2025-07-22
- 2025-08-05
- 2025-10-21
- 2025-11-04
- 2026-02-12
- 2026-02-24
- 2026-04-22
- 2026-05-05
- 2026-07-22
- 2026-08-03
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.